Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine efficacy by investigator-assessed PFS of a combined regimen of obinutuzumab and Venetoclax compared with GClb in previously untreated patients with CLL who have coexisting medical conditions.
Critère d'inclusion
- Chronic lymphocytic leukemia